Donald Trump’s victory in Tuesday’s presidential election, together with the defeat of a California ballot measure, has one industry breathing a sigh of relief, at least for now: pharmaceuticals.

Hospital and insurance companies that have benefited from the Affordable Care Act’s expansion of Medicaid coverage saw a sharp fall in their stock prices on fears a Trump administration could roll back that expansion.

Millions of low-income Americans on Medicaid could lose their health coverage if President-elect Donald Trump and a Republican-controlled Congress follow through on GOP proposals to cut spending in the state-federal insurance program.

Most of Nevada’s hospitals are struggling to make the grade when it comes to patient safety, according to a new report by a national health-care watchdog that placed the state near the bottom of its rankings.

The Affordable Care Act transformed the medical system, expanding coverage to millions, injecting billions in tax revenue, changing insurance rules and launching ambitious experiments in quality and efficiency.

After six controversial years, the Affordable Care Act, aka Obamacare, may be on the way out, thanks to the GOP sweep of the presidency and both houses of Congress Tuesday.